Solid tumor Clinical Trials in Salt Lake City, UT
As of June 2026, 35 paid clinical trials are recruiting for Solid tumor in Salt Lake City, Utah. Recruiting Solid tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Salt Lake City
Filter results
35 clinical trials for Solid tumor
·Clear filters·↓ Download CSVProspective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
QTX3034 in Patients With KRAS G12D Mutation
Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Project: Every Child for Younger Patients With Cancer
About research studies in Salt Lake City
Salt Lake City has approximately 995 recruiting research studies across a wide range of therapeutic areas. Utah hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Salt Lake City
Researchers run research studies in Salt Lake City, UT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Utah | Stroke, Acute Myeloid Leukemia, Amyotrophic Lateral Sclerosis | 211 |
| Huntsman Cancer Institute/University of Utah | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Metastatic Melanoma | 86 |
| Primary Children's Hospital | Neuroblastoma, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia | 68 |
| Huntsman Cancer Institute | Multiple Myeloma, Colorectal Cancer, Endometrial Cancer | 66 |
| Huntsman Cancer Institute, University of Utah | Advanced Solid Tumor, Breast Cancer, HIV Infection | 31 |
| University of Utah Health | Interstitial Lung Disease, Heart Failure, Progressive Pulmonary Fibrosis | 29 |
| Huntsman Cancer Institute at University of Utah | Gynecologic Cancer, Breast Cancer, Marginal Zone Lymphoma | 21 |
| LDS Hospital | Multiple Myeloma, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8 | 20 |
| University of Utah Hospital | Cardiovascular Diseases, Abdominal Aortic Aneurysm, Cirrhosis | 19 |
| University of Utah Sugarhouse Health Center | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 18 |
| Huntsman Cancer Institute at the University of Utah | Multiple Myeloma, Non-Hodgkin Lymphoma, Plasma Cell Leukemia | 17 |
| VA Salt Lake City Health Care System, Salt Lake City, UT | Alcohol Use Disorder (AUD), Atherosclerosis, Carcinoma, Hepatocellular | 14 |
| The University of Utah | ATP-Binding Cassette Subfamily C Member 6 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Bowel; Stricture | 12 |
| Utah Cancer Specialists | Colorectal Cancer, NSCLC, Ovarian Cancer | 12 |
| University of Utah - Huntsman Cancer Institute | Advanced Solid Tumor, Acute Biphenotypic Leukemia, Acute Leukemia | 10 |
| University of Utah Huntsman Cancer Institute | Advanced Melanoma, ARID1A Gene Mutation, Advanced Solid Tumor | 10 |
| Intermountain Healthcare | Large B-cell Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma | 9 |
| University of Utah Orthopaedic Center | Acetabular Fracture, Chronic Low-back Pain, Chronic Pain | 9 |
| Utah Cancer Specialists-Salt Lake City | Anatomic Stage IV Breast Cancer AJCC v8, B Acute Lymphoblastic Leukemia, Castration Levels of Testosterone | 8 |
| University of Utah Healthcare | Intracerebral Hemorrhage, Ischemic Stroke, Atrial Fibrillation | 7 |
| University of Utah Orthopedics | Ankle Injuries, Cervical Myelopathy, Early Mobilization | 7 |
| Clinical Trial Site | Acute Hepatic Porphyria, Advanced Solid Cancer, Breast Cancer | 6 |
| Intermountain Health | Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, Advanced Ovarian Carcinoma | 6 |
| University of Utah Health Sciences Center | Interstitial Lung Diseases, Chronic Cutaneous Lupus Erythematosus, Congestive Heart Failure | 6 |
| University of Utah Medical Center | Obstetrical Complications, HCV, Liver Transplant | 6 |
Active & Upcoming Studies in Salt Lake City (2026)
Recruiting trials in Salt Lake City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (328 active studies)
- Population Health Management -Increase Lung Cancer Screening in Community Health Centers (LungSMART) · University of Utah
- Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma · Phase 2 · University of Utah
Neurology & pain (80 active studies)
- Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease · Phase 4 · VA Office of Research and Development
- Phase 3 Bunionectomy Study · Phase 3 · Cali Pharmaceuticals LLC
Cardiovascular (64 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study · Carelon Research
Diabetes & metabolic (28 active studies)
- Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus · Phase 2 · Hanmi Pharmaceutical Company Limited
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight · Phase 3 · Novo Nordisk A/S
Eye & vision (24 active studies)
- Study of Serine Supplementation to Protect Vision in MacTel · Phase 3 · The Lowy Medical Research Institute Limited
- Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA). · University of Utah
Pediatric (22 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study · Carelon Research
Mental health & behavior (16 active studies)
Vaccines (9 active studies)
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose · Phase 3 · Pfizer
HIV / STI (4 active studies)
- Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma · Phase 1 · AIDS Malignancy Consortium
- Screen Smart: Using Digital Health to Improve HIV Screening and Prevention · Children's Hospital Medical Center, Cincinnati
Common conditions studied in Salt Lake City
- Breast Cancer (21 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Acute Myeloid Leukemia (15 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Multiple Myeloma (14 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Advanced Solid Tumor (13 active studies). Recruiting Advanced Solid Tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Heart Failure (11 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Cancer (9 active studies). Recruiting Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Salt Lake City
- University of Utah
- National Cancer Institute (NCI)
- AstraZeneca
- Children's Oncology Group
- Novartis Pharmaceuticals
Local regulations and guidelines
Clinical trials in Utah are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Utah research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Salt Lake City. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Salt Lake City
Hipa.ai aggregates every recruiting study in Salt Lake City from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Salt Lake City?
There are approximately 995 recruiting clinical trials in Salt Lake City, Utah listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Salt Lake City pay participants?
Most recruiting trials in Salt Lake City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Salt Lake City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Salt Lake City?
The most common conditions under active study in Salt Lake City include Breast Cancer (21), Acute Myeloid Leukemia (15), Multiple Myeloma (14), Advanced Solid Tumor (13), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Salt Lake City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Salt Lake City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Salt Lake City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Salt Lake City?
Recruiting research sites in Salt Lake City include University of Utah, Huntsman Cancer Institute/University of Utah, Primary Children's Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Salt Lake City right now?
The largest active categories in Salt Lake City are Cancer & tumors (328), Neurology & pain (80), Cardiovascular (64). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.